Spirit Aerosystems Holdings, Inc. (NYSE: SPR) unit Spirit AeroSystems and the International Association of Machinists and Aerospace Workers have agreed to a four-year
Genmab A/S (NASDAQ: GMAB) and AbbVie Inc (NYSE: ABBV) have announced topline results from the follicular lymphoma (FL) cohort of the phase 1/2 EPCORE NHL-1 clinical trial evaluating epcoritamab (DuoBody CD3
Cathie Wood‘s Ark Investment Management has regained momentum this year as its actively-managed exchange-traded funds capitalize on the tech rally. Core…